UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 36

Sortiert nach

Second Allogeneic Stem Cell Transplantation in Myeloid Malignancies

Acta haematologica, 2009-01, Vol.122 (4), p.185-192

2009

Volltextzugriff (PDF)

Myeloablative megatherapy with autologous stem-cell rescue versus oral maintenance chemotherapy as consolidation treatment in patients with high-risk neuroblastoma: a randomised controlled trial

The lancet oncology, 2005-09, Vol.6 (9), p.649-658

2005

Volltextzugriff (PDF)

Midkine is highly expressed in neuroblastoma tissues

Pediatric surgery international, 2008-12, Vol.24 (12), p.1355-1359

2008

Volltextzugriff (PDF)

Lack of Thy1 (CD90) expression in neuroblastomas is correlated with impaired survival

Pediatric surgery international, 2008, Vol.24 (1), p.101-105

2008

Volltextzugriff (PDF)

Neuroblastoma Screening at 1 Year of Age: The Final Results of a Controlled Trial

JNCI cancer spectrum, 2021-08, Vol.5 (4)

2021

Volltextzugriff (PDF)

Neuroblastoma Screening at One Year of Age

The New England journal of medicine, 2002-04, Vol.346 (14), p.1047-1053

2002

Volltextzugriff (PDF)

Pretreatment prognostic factors and treatment results in children with hepatoblastoma: A report from the German Cooperative Pediatric Liver Tumor Study HB 94

Cancer, 2002-07, Vol.95 (1), p.172-182

2002

Volltextzugriff (PDF)

Comparison of Two Doses of Antithymocyte Globulin in Patients Undergoing Matched Unrelated Donor Allogeneic Stem Cell Transplantation

Biology of blood and marrow transplantation, 2008-08, Vol.14 (8), p.913-919

2008

Volltextzugriff (PDF)

Ligands for the peroxisome proliferator-activated receptor-γ have inhibitory effects on growth of human neuroblastoma cells in vitro

Toxicology (Amsterdam), 2005-09, Vol.213 (1), p.157-168

2005

Volltextzugriff (PDF)

Anti-thymocyte globulin overcomes the negative impact of HLA mismatching in transplantation from unrelated donors

Experimental hematology, 2008-08, Vol.36 (8), p.1047-1054

2008

Volltextzugriff (PDF)

L1 is associated with favorable outcome in neuroblastomas in contrast to adult tumors

Annals of surgical oncology, 2007-12, Vol.14 (12), p.3575-3580

2007

Volltextzugriff (PDF)

Outcome of HLA-Mismatched Unrelated Donor Allogeneic Stem Cell Transplantation Depends On the Intensity of the Conditioning Regimen

Blood, 2009-11, Vol.114 (22), p.3393-3393

2009

Volltextzugriff (PDF)

Comparable Results of HLA-Mismatched Vs HLA-Matched Unrelated Donors for Allogeneic Stem Cell Transplantation Using Pre-Transplant ATG

Blood, 2008-11, Vol.112 (11), p.966-966

2008

Volltextzugriff (PDF)

Second Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia and Myelodysplastic Syndrome

Blood, 2008-11, Vol.112 (11), p.4308-4308

2008

Volltextzugriff (PDF)

Dose‐reduced conditioning regimen followed by allogeneic stem cell transplantation in patients with myelofibrosis with myeloid metaplasia

British journal of haematology, 2002-12, Vol.119 (3), p.769-772

2002

Volltextzugriff (PDF)

Children may not benefit from neuroblastoma screening at 1 year of age. Updated results of the population based controlled trial in Germany

Cancer letters, 2003-07, Vol.197 (1), p.19-28

2003

Volltextzugriff (PDF)

Faster Immune Reconstitution after Allogeneic Hematopoietic Stem Cell Transplantation of Younger Children Compared with Older Children and Adults

Blood, 2004-11, Vol.104 (11), p.1250-1250

2004

Volltextzugriff (PDF)

Improved outcome in haemophagocytic lymphohistiocytosis after bone marrow transplantation from related and unrelated donors: a single‐centre experience of 12 patients

British journal of haematology, 1999-09, Vol.106 (4), p.1052-1058

1999

Volltextzugriff (PDF)

Lead-time and overdiagnosis estimation in neuroblastoma screening

Statistics in medicine, 2003-09, Vol.22 (18), p.2877-2892

2003

Volltextzugriff (PDF)

Influence of anti-thymocyte globulin as part of the conditioning regimen on immune reconstitution following matched related bone marrow transplantation

Journal of hematotherapy & stem cell research, 2003-04, Vol.12 (2), p.237-242

2003

Volltextzugriff (PDF)

Platinum disposition after intraarterial and intravenous infusion of cisplatin for osteosarcoma

Cancer chemotherapy and pharmacology, 1989, Vol.24 (6), p.376-380

1989

Volltextzugriff (PDF)

Children may not benefit from neuroblastoma screening at 1 year of age. Updated results of the population based controlled trial in Germany: Neuroblastoma - Developmental and molecular biology meet therapy design

Cancer letters, 2003, Vol.197 (1-2), p.19-28

2003

Volltextzugriff (PDF)

Pretreatment prognostic factors and treatment results in children with hepatoblastoma

Cancer, 2002-07, Vol.95 (1), p.172-182

2002

Volltextzugriff (PDF)

Screening for neuroblastoma

The Lancet (British edition), 1994-10, Vol.344 (8930), p.1157-1158

1994

Volltextzugriff (PDF)

Infectious risks of Broviac catheters in children with neoplastic diseases: a matched pairs analysis

The Pediatric infectious disease journal, 1992-12, Vol.11 (12), p.1014-1018

1992

Volltextzugriff (PDF)

1 – 25 von 36

Suche als RSS-Feed

Aktive Filter

ThemaAnimals

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(30)
Mit Volltextzugriff
(35)

Publikationsform

Artikel
(35)
Buchkapitel
(1)

Sprache

Englisch
(36)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Second Allogeneic Stem Cell Transplantation in Myeloid Malignancies

Myeloablative megatherapy with autologous stem-cell rescue versus oral maintenance chemotherapy as consolidation treatment in patients with high-risk neuroblastoma: a randomised controlled trial

Midkine is highly expressed in neuroblastoma tissues

Lack of Thy1 (CD90) expression in neuroblastomas is correlated with impaired survival

Neuroblastoma Screening at 1 Year of Age: The Final Results of a Controlled Trial

Neuroblastoma Screening at One Year of Age

Pretreatment prognostic factors and treatment results in children with hepatoblastoma: A report from the German Cooperative Pediatric Liver Tumor Study HB 94

Comparison of Two Doses of Antithymocyte Globulin in Patients Undergoing Matched Unrelated Donor Allogeneic Stem Cell Transplantation

Ligands for the peroxisome proliferator-activated receptor-γ have inhibitory effects on growth of human neuroblastoma cells in vitro

Anti-thymocyte globulin overcomes the negative impact of HLA mismatching in transplantation from unrelated donors

L1 is associated with favorable outcome in neuroblastomas in contrast to adult tumors

Outcome of HLA-Mismatched Unrelated Donor Allogeneic Stem Cell Transplantation Depends On the Intensity of the Conditioning Regimen

Comparable Results of HLA-Mismatched Vs HLA-Matched Unrelated Donors for Allogeneic Stem Cell Transplantation Using Pre-Transplant ATG

Second Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia and Myelodysplastic Syndrome

Dose‐reduced conditioning regimen followed by allogeneic stem cell transplantation in patients with myelofibrosis with myeloid metaplasia

Children may not benefit from neuroblastoma screening at 1 year of age. Updated results of the population based controlled trial in Germany

Faster Immune Reconstitution after Allogeneic Hematopoietic Stem Cell Transplantation of Younger Children Compared with Older Children and Adults

Improved outcome in haemophagocytic lymphohistiocytosis after bone marrow transplantation from related and unrelated donors: a single‐centre experience of 12 patients

Lead-time and overdiagnosis estimation in neuroblastoma screening

Influence of anti-thymocyte globulin as part of the conditioning regimen on immune reconstitution following matched related bone marrow transplantation

Platinum disposition after intraarterial and intravenous infusion of cisplatin for osteosarcoma

Children may not benefit from neuroblastoma screening at 1 year of age. Updated results of the population based controlled trial in Germany: Neuroblastoma - Developmental and molecular biology meet therapy design

Pretreatment prognostic factors and treatment results in children with hepatoblastoma

Screening for neuroblastoma

Infectious risks of Broviac catheters in children with neoplastic diseases: a matched pairs analysis

Aktive Filter

Suchergebnisse filtern